Physiopathology of symptomatic and latent forms of central nervous hyperexcitability due to magnesium deficiency: A current general scheme

Magnesium Research

Volumn 13, Issue 4, 2000, Pages 293-302

  Durlach, Jean ^a   Bac, Pierre ^b   Bara, Michel ^c   Guiet Bara, Andrée ^c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Laboratoire de Pharmacognosie   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Antioxidant defence; Cationic gradient; Excitatory neuromediators; Inflammatory mediators; Inhibitory neuromediators; Magnesium; Nervous hyperexcitability; Opioids; Peroxidations; Polyamines; Second messenger nucleotidic ratio; Sulfur compounds

Indexed keywords

CALCIUM; MAGNESIUM;

ANIMAL; BIOLOGICAL MODEL; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; MAGNESIUM DEFICIENCY; METABOLISM; MOUSE; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; BRAIN; CALCIUM; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; MICE; MODELS, BIOLOGICAL; PAIN; RATS;

EID: 0034567152     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Durlach, J., Bac, P., Durlach, V., Bara, M. & Guiet-Bara, A. (1997): Neurotic, neuromuscular and autonomie nervous form of magnesium imbalance. Magnes. Res. 10, 169-195.
2. Durlach, J. (1998): Aetiology and pathophysiology of central nervous hyperexcitability due to various types of magnesium deficit : magnesium deficiency and magnesium depletion. In: Magnesium: magnesium and magnesium interaction of magnesium with trace elements. Hung. Med. Soc. Budapest: 11-16.
3. Durlach J. (1995): Editorial Policy of Magnesium Research: general considerations on the quality criteria for biomedical papers. Some complementary guidelines for the contributors of Magnesium Research. Magnes. Res. 8, 191-206.
4. Lasserre, B., Theubet, M.P., Spoerri, M. & Luccarini, Y. (1991): Marginal magnesium deficiency : Cross-sectional and follow up study in an outpatient setting. In: Magnesium - a relevant ion, eds B. Lasserre & J. Durlach, pp. 59-71. London; John Libbey.
5. Martignoni, E., Blandini, F., Costa, A., Sandrini, G., Verri, A.P. & Nappi, G. (1994): Modulation of noradrenergic activity by magnesium salts in panic disorder and neuronal hyperexcitability syndrome. Med. Sci. Res. 22, 429-430.
6. Durlach, J., Poenaru, S., Rouhani, S., Bara, M. & Guiet-Bara, A. (1987) : The control of central neural hyperexcitability in magnesium deficiency. In: Nutrients and brain Junction, ed. W.B.Essman, pp. 48-71. Basel, New York : Karger.
7. Lerna, A., Flanells, E., Aranda, P. & Llopis, J. (1993): Evolution of magnesium deficiency in rats. Ann. Nutr. Metabol. 37, 210-217.
8. Standley, C.A. & Cotton, D.B. (1996): Brain ionized Mg and Ca levels during magnesium supplementation and deficiency in female Long-Evans Rats. Obst. Gynecol. 88, 184-188.
9. Durlach, J. & Bac, P. (1997): Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Mineral and metal neurotoxicology. eds M. Yasui, M.J. Strong, K. Ota & M.A. Verity, pp. 201-203. Boca-Raton: CRC Press.
10. Poenaru, S., Manicom, R., Rouhani, S., Aymar, P., Bajenaru, O., Rayssiguier, Y., Emmanouillidis, E., Gueux, E., Nkanga, N., Durlach, J. & Dall'ava, J. (1997): Stability of brain content of magnesium in experimental hypomagnesemia. Brain Res. 769, 329-332.
11. Durlach, J., Durlach, V., Rayssiguier, Y., Ricquier, D., Goubern, M., Bertin, R., Bara, M., Guiet-Bara, A., Olive, G. & Mettey, R. (1991): Magnesium and thermo-regulation I. Newborn and infant. Is Sudden Death Syndrom a magnesium-dependent disease of the transition from chemical to physical thermo-regulation? Magnes. Res. 4, 137-152.
12. Chutkow, J.G. (1990): Magnesium and the central (intradural) nervous system: metabolism, neurophysiological functions, and clinical disorders. In: II. Sigel and A. Sigel eds. Metal ions in biological systemsvol. 26. Compendium on magnesium and its role in biology, nutrition and physiology, eds H. Sigel & A. Sigel, pp. 441-462. New York, Basel: Dekker.
13. Mitani, K. (1992): Relationship between neurological diseases due to Al load, especially amyotrophic lateral sclerosis and magnesium status. Magnes. Res. 5, 203-213.
14. 31P-NMR. Biochem. Biophys. Acta. Mol. Cell. Res. 1358, 1-5.
15. Planells, E., Aranda, P. & Llopis, J. (2000): Effects of magnesium deficiency on iron and magnesium content in different rat brain structures (abst.) Magnes. Res. 13, 68.
16. Durlach, J. & Bara M. (2000): Le magnésium en biologie et en médecine. Paris: EM Inter Lavoisier, 416 pp.
17. Li, W., Zheng, T., Altura, B.T. & Altura, B.M. (2000): Antioxidants prevent elevation in [Ca(2+)] (i) induced by low extracellular magnesium in cultured canine cerebral vascular smooth muscle cells: possible relationship to Mg(2+) deficiency-induced vasospasm and stroke. Brain Res. Bull. 52, 151-154.
18. Nakanishi, H., Karnata, O., Ukai, K. & Yamamoto, K. (1991): Inhibitory effects of NMDA antagonists on hypoxia-induced seizures in dietary magnesium deficient mice. Eur. J. Pharmacol. 204, 29-34.
19. Bac, P., Pages, N., Herrenknecht, C., Dewulf, C., Binet, P. & Durlach, J. (1994): Effect of various serotoninergically induced manipulations on audiogenic seizures in magnesium-deficient mice. Magnes. Res. 7, 107-115.
20. Nakamura, M., Abe, S., Goto, Y., Chishakis, S., Akazawa, K. & Kalo, M. (1994): In vivo assessment of prevention of white-noise-induced seizure in Mg-deficient rats by NMDA receptor blockers. Epilepsy Res. 17, 249-256.
21. Nakamura, M., Abe, S. & Akazawa, K. (1995): AMPA - but not NMDA - receptor blocker NBQX prevents seizure induction in Mg-deficient rats. Magnes. Res. 8, 55-56.
22. Okada, M., Mizuno, K., Okuyama, M. & Kaneko, S. (1996): Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in rat striatum. Psychiatry Clin. Neurose. 50, 147-156.
23. 2+ and adenosine on monoaminergic system in the central nervous system. Magnes. Res. 11, 289-305.
24. Przewlocka, B., Machelska, H. & Lason, W. (1994): Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse. Ear. Neuropsychopharmacol. 4, 527-533.
25. 2+. J. Neurochem. 62, 916-922.
26. Westergaard, N., Sommewald, U., Unsgard, G., Peng, L., Hertz, L. & Schousboe, A. (1994): Uptake, release and metabolism of citrate in neurons and astrocytes in primary cultures. J. Neurochem. 62, 1727-1733.
27. Forster, I. & Bertrand, D. (1995): Inward rectification of neuronal nicotinic acetylcholine receptor investigating by using the homomeric α7 receptor. Proc. R. Soc. Lond. B. 260, 139-148.
28. Wegmann, T.G., Lin, H., Guilbert, L. & Mosmann, T.R. (1993): Bidirectional cytokine interactions in the maternal-fetal interrelationship: is successful pregnancy a Th2 phenomenon? Immunol. Today 14, 353-356.
29. Deneys, V., Van der Lierde, M. and de Bruyère, M. (1995): Tolérance immunologique de l'allogreffe foetale.Pr. Méd., 24, 1651-1657.
30. Weglicki, W.B. & Phillips, T.M. (1992): Pathobiology of Mg deficiency : a cytokine - neurogenic inflammation hypothesis. Am. J. Physiol. 263, R734-R737.
31. Rayssiguier, Y., Gueux, E., Bussière, L., Durlach, J. & Mazur A. (1993): Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxydation in rats. J. Am. Coll. Nutr. 12, 133-137.
32. Rayssiguier, Y., Durlach, J., Gueux, E., Rock, E. & Mazur, A. (1993): Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes. Res. 6, 369-378.
33. Gunther, T., Schumann, K. & Vormann, J. (1995): Tumor necrosis factor-α, prostanoids and immunoglobulins in magnesium deficiency. Magnes. Bull. 17, 109-114.
34. Rock, E., Astier, C., Lab, C., Malpuech, C., Nowacki, W., Gueux, E., Mazur, A. & Rayssiguier, Y. (1995): Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 8, 237-242.
35. Mak, I.J., Komarov, A.M., Wagner, T.L., Stafford, R.E., Dickens, B.F. & Weglicki, W.B. (1996): Enhance NO production during magnesium deficiency and its role in mediating red blood cell glutathione loss. Am. J. Physiol. 271, C385-C390.
36. Weglicki, W.B., Dickens, B.F., Wagner, T.L., Chmielinska, J.J. & Philipps, T.M. (1996): Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocyte from magnesium-deficient mice. Magnes. Res. 9, 3-11.
37. Maurois, P., Bernigaud, A. & Jouault, P. (1993): Comparative cytotoxic activity of tumour necrosis factor (TNFα) in two mouse strains fed a severe magnesium-deficient diet (abst.) Magnes. Res. 6, 307.
38. Velloso Da Costa, A. (1996): Magnesium, antioxidants and longevity. In: Current research in magnesium, eds M.J. Halpern & J. Durlach, pp. 265-268. Publ. London: John Libbey.
39. t 5): S20-S24.
40. Birnbaver, L., Abramowitz, J. & Brown A.M. (1990): Receptor effector coupling by G proteins. Bioch. Biophys. Acta 1013, 163-224.
41. 2 activity in mitochondria by magnesium and polyamines. Magnes. Res. 7, 5-10.
42. 2+ and polyamines of excitatory aminoacid currents in rodent neurones in culture. Magnes. Res. 9, 317-327.
43. Seizinger, B.R., Höllt, V. & Herz, A. (1982): Dynorphin-related opioid peptides in the neurointermediate pituitary of rats not α-N-acetylated. J. Neurochem. 39, 143-148.
44. Durlach, J., Durlach, V., Bac, P., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1993): Magnesium and ageing. II. Clinical data: aetiological mechanisms and pathophysiological consequences of magnesium deficit in the elderly patients. Magnes. Res. 6, 379-394.
45. Bac, P., Herrenknecht, C., Binet, P. & Durlach, J. (1993): Audiogenic seizures in magnesium-deficient mice: effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyltaurinate, magnesium chloride and vitamine B-6. Magnes., Res. 6, 11-19.
46. Bac, P., Herrenknecht, C., Pages, N., Dupont, C. & Durlach, J. (1996): Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium deficient rats: I. Comparative study of various magnesium salts. Magnes. Res. 9, 281-292.
47. 2+and other divalent cations on the binding of triated opioid ligands. J. Neurochem. 59, 467-472.
48. Bourhim, N., Castanas, E., Giraud, P. & Oliver, C. (1993): Differential modulation of solubilized opioid binding sites by cations in the bovine adrenal medulla. Mol. Neuropharmacol. 3, 139-146.
49. Worig, C.S., Su, Y.F., Watkins, D. & Chang, K.J. (1994): Opioid agonist binding affinity is increased by magnesium in the presence of guanosine di phosphate but decreased by magnesium in the presence of guanyl-5′-ylimidodiphosphate. J. Pharmacol. Exp. Ther. 268, 653-661.
50. Lupp, A., Lucking, C.H., Koch, R., Jackisch, R. & Feuerstein, J. (1992): Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on the NMDA evoked acetylcholine release in the rabbit caudate nucleus. J. Pharmacol. Exp. Ther. 263, 717-724.
51. Cho, B.K. & Yoon, Y.B. (1993): Influence of adenosine and magnesium on acetylcholine release in the rat hippocampus. Korean J. Pharmacol. 29, 175-182.
52. Krumins, S.A., Kim, D.C., Igwe, O.J. & Larson, A.A. (1993): DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P and substance P fragment. Peptides 14, 309-314.
53. Rothe, F., Wolf, G., Fisher, S., Hass, P., Keilhoff, G. & Abicht, K. (1993): Quinolate and kainate facilitate magnesium penetration into brain tissue. Neuro-Report 4, 205-207.
54. 2+ release from pre-labelled adult rat hippocampus in vivo. Acta Neurobiol. Exp. 55, 223-231.
55. Lehmann, A., Lazarewicz, J.W. and Zeise, M. (1985): N-methylaspartate-evoked liberation of taurine and phosphoethanolamine in vivo: site of release. J. Neurochem. 45, 1172-1177.
56. 2+homeostasis in developing and adult rat striaturn: in vivo microdialysis approach. Int. J. Dev. Neuroscience 13, 695-704.
57. Murasato, Y., Harada, Y., Ikeda, M., Nakashima, Y. & Hayashida, Y. (1999): Effects of magnesium deficiency on autonomie circulatory regulation in conscious rats. Hypertension 34, 247-252.
58. Depoortere, H., Françon, D. & Llopis, J. (1993): Effects of a magnesium deficient diet on sleep organisation in rats. Neuropsychobiology 27, 237-245.
59. Bac, P., Herrenknecht, C. & Dupont, C. (1996): Effects of magnesium acetyltaurinate and morphine hydrochloride on hot plate test in magnesium deficient mice (abst). Magnes. Res. 9, 239.
60. Dubray, C. & Rayssiguier, Y. (1997): Magnesium, inflammation and pain. In: Magnesium: Current status and new developments. eds T. Theophanides & J. Anastassopoulou, pp. 303-311. Dordrecht: Kluwer.
61. Durlach, J. (1988) : Le N-acétylhomotaurinate de calcium: une thérapeutique nouvelle de l'alcoolisme à sites d'action pharmacologique multiples. La Revue de l'Alcoolisme. 33, 229-252.
62. Nishiyama, T., Yaksh, T.L. & Weber, E. (1998): Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Anesthesiology 89, 715-722.
63. 2+. Neuropharmacology 38, 991-998.
64. Tzschentke, T.M. & Schmidt, W.J. (1996): Morphine induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist. Eur. J. Pharmacol 295, 137-146.